Related Experiment Video
Updated: Jun 16, 2026
09:15
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Automated regional citrate anticoagulation: technological barriers and possible solutions
Balazs Szamosfalvi1, Stanley Frinak, Jerry Yee
1Division of Nephrology and Hypertension, Henry Ford Health System, Detroit, Mich., USA. bszamos1@hfhs.org
Blood Purification
|January 23, 2010
Summary
Safe regional citrate anticoagulation (RCA) for dialysis is now feasible with a new protocol. This automated system prevents clotting and electrolyte issues in critically ill patients, improving dialysis safety.
Area of Science:
- Nephrology and Critical Care Medicine
- Biomedical Engineering
Background:
- Traditional regional citrate anticoagulation (RCA) presents risks hindering widespread adoption.
- There is a critical need for safe, automated RCA protocols compatible with dialysis systems.
Purpose of the Study:
- To develop and evaluate a novel protocol for safe and automated regional citrate anticoagulation (RCA) during sustained low-efficiency dialysis (SLED).
- To assess the feasibility of integrating automated calcium infusion for maintaining electrolyte balance during SLED-RCA.
Main Methods:
- Applied kinetic analysis of solute fluxes to design a SLED-RCA protocol.
- Utilized a high-flux dialyzer, zero-calcium dialysate, and online monitoring systems.
- Implemented an automated calcium (Ca) infusion system adjusted hourly based on hematocrit and albumin levels.
Main Results:
- The SLED-RCA protocol effectively prevented clotting in an ex vivo system and clinically, without adverse electrolyte disturbances.
- Automated calcium infusion maintained normal systemic ionized calcium (iCa) levels (0.95-1.4 mmol/l).
- High citrate extraction by the dialyzer prevented systemic citrate accumulation, even in patients with liver dysfunction.
Conclusions:
- Automated SLED-RCA is feasible with predictive calcium dosing and integrated dialysis machine control.
- This approach offers a user-friendly and safe system for anticoagulation in dialysis, particularly for critically ill patients.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...